Showing 84,981 - 85,000 results of 85,858 for search '(progres OR programs)', query time: 0.40s Refine Results
  1. 84981
  2. 84982
  3. 84983
  4. 84984
  5. 84985
  6. 84986

    USE OF QUANTUM-CHEMICAL PARAMETERS FOR FORECASTING ANTIRADICAL (HO·) ACTIVITY OF RELATED STRUCTURES CONTAINING A CINNAMIC MOLD FRAGMENT. III. CHALCONES, FLAVANONES AND FLAVONES WIT... by E. T. Oganesyan, S. S. Shatokhin

    Published 2021-05-01
    “…The calculations of the listed above parameters with the use of the semi-empirical method PM7 (WinMopac 2016 program) have been carried out on a workstation with an Intel Xeon E5-1620 3.5 GHz processor, 20 GB of RAM.Results. …”
    Get full text
    Article
  7. 84987
  8. 84988
  9. 84989

    Structural Changes in the Dynamics of China’s Exports and Imports by V. V. Narbut, T. I. Chinaeva, E. I. Larionova

    Published 2024-05-01
    “…The analysis was carried out using the Statistica 10.0 program.Results. A change in the value of the import coverage ratio by exports was revealed before and after structural changes in the dynamics of the main foreign economic indexes and an assessment of their statistical significance was given. …”
    Get full text
    Article
  10. 84990

    PLANNING IN ARTIFICIAL INTELLIGENCE AND ROBOTICS (PAIR) by Editorial, Foreword

    Published 2016-11-01
    “…Fourteen papers have accepted and listed in the conference program. The papers have been authored by students from Central Europe, in particular from Czechia, Germany, Poland, and Slovakia. …”
    Get full text
    Article
  11. 84991
  12. 84992
  13. 84993

    Application of <i>in vitro</i> studies to predict the pharmacokinetics of rivaroxaban tablets by A. V. Suvorova, P. A. Losenkova, Yu. V. Medvedev, E. A. Malashenko, K. K. Karnakova, N. S. Bagaeva, A. Yu. Savchenko, A. M. Poluyanov, I. E. Shohin

    Published 2024-09-01
    “…Pharmacokinetic profiles were modeled in the PK-Sim® (Systems Biology Software Suite 11.2, Bayer Technology Services GmbH, Germany) program based on the data obtained within the physiologically relevant test. …”
    Get full text
    Article
  14. 84994
  15. 84995
  16. 84996

    Spatiotemporal distribution of newly diagnosed echinococcosis patients in Sichuan Province, China, 2013-2024. by Wei He, Yang Liu, Bo Zhong, Wenjie Yu, Sha Liao, Guangjia Zhang, Qi Wang, Ruirui Li, Liu Yang, Renxin Yao, Zhongshuang Zhang, Yan Huang, Liying Wang, Qian Wang

    Published 2025-08-01
    “…<h4>Methods</h4>Data on the number of individuals screened for echinococcosis and the number of newly diagnosed patients in endemic counties were obtained from the annual reports of the Sichuan Provincial Echinococcosis Control Program between 2013 and 2024. The detection rate of newly diagnosed echinococcosis patients was calculated for each year. …”
    Get full text
    Article
  17. 84997
  18. 84998

    Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study by Liu J, Wang Y, Cui L, Nie Y, Li C, Tan W, Li Y, Bai Y, Wan T, Hu B, Liu Z, Hu M, Wang M, Duan F

    Published 2025-07-01
    “…Jiangtao Liu,1,&amp;ast; Yan Wang,2,&amp;ast; Li Cui,2 Yan Nie,1 Chao Li,1 Wenle Tan,2 Ye Li,1 Yanhua Bai,1 Tao Wan,3 Bingyang Hu,3 Zhe Liu,3 Minggen Hu,3 Maoqiang Wang,2 Feng Duan2 1Department of Gastroenterology, Hainan Hospital of Chinese People’s Liberation Army (PLA) General Hospital, Sanya, Hainan, 572000, People’s Republic of China; 2Department of Interventional Radiology, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, 100853, People’s Republic of China; 3Faculty of Hepato-Biliary-Pancreatic Surgery, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, 100853, People’s Republic of China&amp;ast;These authors contributed equally to this workCorrespondence: Feng Duan, Email duanfeng@vip.sina.comObjective: This study aims to compare the effectiveness and safety of TACE combined with molecular targeted therapy (MTT) plus Programmed death-ligand 1 (PD-(L)1) antibodies versus MTT plus PD-(L)1 antibodies for HCC patients.Methods: Data from HCC patients who received either MTT plus PD-(L)1 (systemic therapy group) or TACE combined with MTT plus PD-(L)1 (combination therapy group) were retrospectively analyzed. …”
    Get full text
    Article
  19. 84999

    Adherence to four healthy lifestyle factors and their influencing factors among residents aged 35–75 years in Gansu province by Yixuan LI, Peiyuan GAO, Jing ZHANG, Bin WANG, Chouji ZHANG

    Published 2025-03-01
    “…MethodsData were collected from December 2015 to December 2022 as part of the Early Screening and Comprehensive Intervention Program for High-Risk Cardiovascular Disease Populations. …”
    Get full text
    Article
  20. 85000